Apex Healthcare Bhd (7090) - Total Assets
Based on the latest financial reports, Apex Healthcare Bhd (7090) holds total assets worth RM998.30 Million MYR (≈ $250.64 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 7090 net asset value for net asset value and shareholders' equity analysis.
Apex Healthcare Bhd - Total Assets Trend (2012–2024)
This chart illustrates how Apex Healthcare Bhd's total assets have evolved over time, based on quarterly financial data.
Apex Healthcare Bhd - Asset Composition Analysis
Current Asset Composition (December 2024)
Apex Healthcare Bhd's total assets of RM998.30 Million consist of 53.6% current assets and 46.4% non-current assets.
| Asset Category | Amount (MYR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 21.0% |
| Accounts Receivable | RM192.49 Million | 19.1% |
| Inventory | RM132.35 Million | 13.1% |
| Property, Plant & Equipment | RM264.87 Million | 26.3% |
| Intangible Assets | RM9.14 Million | 0.9% |
| Goodwill | RM0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Apex Healthcare Bhd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Apex Healthcare Bhd stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Apex Healthcare Bhd's current assets represent 53.6% of total assets in 2024, a decrease from 70.3% in 2012.
- Cash Position: Cash and equivalents constituted 21.0% of total assets in 2024, up from 4.8% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is property, plant & equipment at 26.3% of total assets.
Apex Healthcare Bhd Competitors by Total Assets
Key competitors of Apex Healthcare Bhd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$46.10 Million |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥235.37 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥89.76 Billion |
Apex Healthcare Bhd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.35 | 3.29 | 2.82 |
| Quick Ratio | 2.56 | 2.47 | 2.16 |
| Cash Ratio | 0.00 | 1.27 | 0.00 |
| Working Capital | RM392.14 Million | RM382.10 Million | RM256.28 Million |
Apex Healthcare Bhd - Advanced Valuation Insights
This section examines the relationship between Apex Healthcare Bhd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.42 |
| Latest Market Cap to Assets Ratio | 0.47 |
| Asset Growth Rate (YoY) | -10.1% |
| Total Assets | RM1.01 Billion |
| Market Capitalization | $473.43 Million USD |
Valuation Analysis
Below Book Valuation: The market values Apex Healthcare Bhd's assets below their book value (0.47x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Apex Healthcare Bhd's assets decreased by 10.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Apex Healthcare Bhd (2012–2024)
The table below shows the annual total assets of Apex Healthcare Bhd from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | RM1.01 Billion ≈ $253.30 Million |
-10.13% |
| 2023-12-31 | RM1.12 Billion ≈ $281.85 Million |
+50.63% |
| 2022-12-31 | RM745.26 Million ≈ $187.11 Million |
+9.57% |
| 2021-12-31 | RM680.14 Million ≈ $170.76 Million |
+9.54% |
| 2020-12-31 | RM620.92 Million ≈ $155.89 Million |
+6.47% |
| 2019-12-31 | RM583.17 Million ≈ $146.41 Million |
+8.00% |
| 2018-12-31 | RM539.97 Million ≈ $135.57 Million |
+18.18% |
| 2017-12-31 | RM456.90 Million ≈ $114.71 Million |
+9.20% |
| 2016-12-31 | RM418.41 Million ≈ $105.05 Million |
+7.28% |
| 2015-12-31 | RM390.00 Million ≈ $97.92 Million |
+10.17% |
| 2014-12-31 | RM354.00 Million ≈ $88.88 Million |
+13.10% |
| 2013-12-31 | RM313.00 Million ≈ $78.58 Million |
+7.93% |
| 2012-12-31 | RM290.00 Million ≈ $72.81 Million |
-- |
About Apex Healthcare Bhd
Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, ant… Read more